בלסטווין טבע

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

VINBLASTINE SULFATE

Disponible desde:

ABIC MARKETING LTD, ISRAEL

Código ATC:

L01CA01

formulario farmacéutico:

תמיסה להזרקה

Composición:

VINBLASTINE SULFATE 1 MG / 1 ML

Vía de administración:

תוך-ורידי

tipo de receta:

אין צורך במרשם

Fabricado por:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

Grupo terapéutico:

VINBLASTINE

Área terapéutica:

VINBLASTINE

indicaciones terapéuticas:

Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma: - Reticulum-cell sarcoma - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Fecha de autorización:

2016-08-31